6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma/Benralizumab
Award Notice Posted
- Solicitation number
- 36E79720R0068
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Astrazeneca Pharmaceuticals LP
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79721D0007 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Award Notice from the Department of Veterans Affairs National Acquisition Center awarded contract 36E79721D0007 to AstraZeneca Pharmaceuticals LP on January 19, 2021 for the provision of subcutaneous anti-interleukin monoclonal antibodies for the treatment of asthma, specifically benralizumab, under solicitation 36E79720R0068. The contract value is $377,812,500.00 for line item number 2 to supply monoclonal antibodies over the period of performance.
Notice text
Awarded contract 36E79721D0007 to ASTRAZENECA PHARMACEUTICALS LP for 377812500.00000000 on 2021-01-19.
Files
| File | Type | Posted |
|---|---|---|
| 36E79721D0007_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| 6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma (VA-21-00000590) | Solicitation | |
| 6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma (VA-21-00000590) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity